These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36106377)

  • 1. Identification of patients with drug-resistant epilepsy in electronic medical record data using the Observational Medical Outcomes Partnership Common Data Model.
    Castano VG; Spotnitz M; Waldman GJ; Joiner EF; Choi H; Ostropolets A; Natarajan K; McKhann GM; Ottman R; Neugut AI; Hripcsak G; Youngerman BE
    Epilepsia; 2022 Nov; 63(11):2981-2993. PubMed ID: 36106377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient characteristics and antiseizure medication pathways in newly diagnosed epilepsy: Feasibility and pilot results using the common data model in a single-center electronic medical record database.
    Spotnitz M; Ostropolets A; Castano VG; Natarajan K; Waldman GJ; Argenziano M; Ottman R; Hripcsak G; Choi H; Youngerman BE
    Epilepsy Behav; 2022 Apr; 129():108630. PubMed ID: 35276502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An algorithm for drug-resistant epilepsy in Danish national registers.
    Bølling-Ladegaard E; Dreier JW; Christensen J
    Brain; 2024 Sep; ():. PubMed ID: 39255058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value contribution of cenobamate for the treatment of Focal-Onset Seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through reflective Multi-Criteria Decision Analysis (MCDA).
    Falip M; López González FJ; Martín-Herranz I; Merino-Bohórquez V; Montoya J; Rey Gómez-Serranillos I; Rodriguez Uranga JJ; Ruiz E; Sancho-López A; Trillo Mata JL; Antoni Vallès J; Álvarez-Barón E; Sabaniego J; Subías-Labazuy S; Gil A
    Epilepsy Behav; 2023 Aug; 145():109350. PubMed ID: 37480633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Recommended Neurodiagnostic Evaluation Among Patients With Drug-Resistant Epilepsy.
    Spotnitz M; Ekanayake CD; Ostropolets A; McKhann GM; Choi H; Ottman R; Neugut AI; Hripcsak G; Natarajan K; Youngerman BE
    JAMA Neurol; 2024 May; 81(5):499-506. PubMed ID: 38557864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying key unmet needs and value drivers in the treatment of focal-onset seizures (FOS) in patients with drug-resistant epilepsy (DRE) in Spain through Multi-Criteria Decision Analysis (MCDA).
    Villanueva V; Carreño M; Gil-Nagel A; Serrano-Castro PJ; Serratosa JM; Toledo M; Álvarez-Barón E; Gil A; Subías-Labazuy S
    Epilepsy Behav; 2021 Sep; 122():108222. PubMed ID: 34371462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Evaluation of Computable Phenotypes in Pediatric Epilepsy:3 Cases.
    Pan S; Wu A; Weiner M; M Grinspan Z
    J Child Neurol; 2021 Oct; 36(11):990-997. PubMed ID: 34315300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing research in symptomatic uterine fibroids with development of a computable phenotype for use with electronic health records.
    Hoffman SR; Vines AI; Halladay JR; Pfaff E; Schiff L; Westreich D; Sundaresan A; Johnson LS; Nicholson WK
    Am J Obstet Gynecol; 2018 Jun; 218(6):610.e1-610.e7. PubMed ID: 29432754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistant epilepsy and associated factors among children with epilepsies in tanzania: a cross-sectional study.
    Urio OH; Kija E; Weckhuysen S; Makungu H; Naburi H
    BMC Neurol; 2024 Jan; 24(1):8. PubMed ID: 38166885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug-resistant epilepsy in England.
    Raspin C; Shankar R; Barion F; Pollit V; Murphy J; Sawyer L; Danielson V
    J Med Econ; 2021; 24(1):1037-1051. PubMed ID: 34348576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterising people with focal drug-resistant epilepsy: A retrospective cohort study.
    Benoist C; Boccaletti S; Leach JP; Cattaneo A; Chaplin A; Antunes L; Heiman F; Sander JW
    Epilepsy Behav; 2023 Dec; 149():109540. PubMed ID: 38006844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of a computable phenotype to identify pediatric patients with leukemia and lymphoma treated with chemotherapy using electronic health record data.
    Phillips CA; Razzaghi H; Aglio T; McNeil MJ; Salvesen-Quinn M; Sopfe J; Wilkes JJ; Forrest CB; Bailey LC
    Pediatr Blood Cancer; 2019 Sep; 66(9):e27876. PubMed ID: 31207054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitating phenotype transfer using a common data model.
    Hripcsak G; Shang N; Peissig PL; Rasmussen LV; Liu C; Benoit B; Carroll RJ; Carrell DS; Denny JC; Dikilitas O; Gainer VS; Howell KM; Klann JG; Kullo IJ; Lingren T; Mentch FD; Murphy SN; Natarajan K; Pacheco JA; Wei WQ; Wiley K; Weng C
    J Biomed Inform; 2019 Aug; 96():103253. PubMed ID: 31325501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Standardized Mortality Ratio and Utilization of Care in US Veterans With Drug-Resistant Epilepsy Compared With All US Veterans and the US General Population.
    Haneef Z; Rehman R; Husain AM
    JAMA Neurol; 2022 Sep; 79(9):879-887. PubMed ID: 35969384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Hypertension in Electronic Health Records Through Computable Phenotype Development and Validation for Use in Public Health Surveillance: Retrospective Study.
    Valvi N; McFarlane T; Allen KS; Gibson PJ; Dixon BE
    JMIR Form Res; 2023 Dec; 7():e46413. PubMed ID: 38150296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of the THIN database in the OMOP Common Data Model for active drug safety surveillance.
    Zhou X; Murugesan S; Bhullar H; Liu Q; Cai B; Wentworth C; Bate A
    Drug Saf; 2013 Feb; 36(2):119-34. PubMed ID: 23329543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scoping review of rational polytherapy in patients with drug-resistant epilepsy.
    Grinalds MS; Yoder C; Krauss Z; Chen AM; Rhoney DH
    Pharmacotherapy; 2023 Jan; 43(1):53-84. PubMed ID: 36484111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of drug resistance in a validated cohort of incident epilepsy patients in the Danish National Patient Register.
    Bølling-Ladegaard E; Dreier JW; Christensen J
    Epilepsia; 2023 Oct; 64(10):2604-2616. PubMed ID: 37505892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early prediction of drug-resistant epilepsy using clinical and EEG features based on convolutional neural network.
    Yang S; Li S; Wang H; Li J; Wang C; Liu Q; Zhong J; Jia M
    Seizure; 2024 Jan; 114():98-104. PubMed ID: 38118285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Structured Electronic Health Records Data Elements for the Development of Computable Phenotypes to Identify Potential Adverse Events Associated with Intravenous Immunoglobulin Infusion.
    Hurst JH; Brucker A; Zhao C; Driscoll H; Hostetler HP; Phillips M; Rosenberg B; Samsky MD; Smith I; Reller ME; Strouse JJ; Zhou CK; Dores GM; Wong HL; Goldstein BA
    Drug Saf; 2023 Mar; 46(3):309-318. PubMed ID: 36826707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.